Biosynthetic Technologies

Series-A
biosynthetic.com Biotech & Healthcare Indianapolis, United States
Total Funding $18M
Latest Round $8M Series-A
Last Announced Feb 2, 2022
Investors 4 Backers
Decision Makers 6 Available

About Biosynthetic Technologies

Biosynthetic Technologies manufactures biobased synthetic molecules that are made from organic fatty acids found in plant oils.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters Indianapolis, United States
Tracked Since Nov 17, 2026

Web & Domain Identity

Official Website biosynthetic.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised $8,000,000 · Series-A

    startupintros.com

  2. Capital Raise

    Raised $10,000,000 · Series-A

    Backed by HG Ventures

Investors & Backers

4
HG Ventures
Lead
BP Ventures
Evonik Venture Capital
U.S. Department of Agriculture

Funding History

2 Rounds
Series-A equity · Feb 2, 2022
Series-A equity · May 1, 2019

Round backers: HG Ventures

Founders & Leadership

4

Gregory Hidden

Director, Strategic Development

Work email & phone locked Unlock →

Jakob Hidden

Founder

Work email & phone locked Unlock →

Jeremy Hidden

EVP Strategy & General Counsel

Work email & phone locked Unlock →

Matthew Hidden

Chief Executive Officer

Work email & phone locked Unlock →

Press Coverage & Sources

More Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts